Atlas Trials

HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes

Clinical trial NCT06550063 · RECRUITING

Trial details

NCT number
NCT06550063
Sponsor
St. James's Hospital, Ireland
Status
RECRUITING
Study type
OBSERVATIONAL
Esophagus CancerGastric CancerHER2-positive CancerHER2-low Cancer
Start date
2024-08-20
Primary completion
2025-05-31
Enrollment
2188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.